From the Desk of Kimmy Sokoloff
$MSFT reported last night, and, at first, it rallied above $250. And then management had their conference call.
We’ll see how it acts, if dip-buyers show up or it just heads back down to $226.
Swing Trader Pro: Afternoon Briefing (01-24-2023)
There was a major glitch at the New York Stock Exchange today, and it really did a number on the opening of the market.
Prices were all over the place, and names were halted.
Three of my positions below went to my target. But due to the glitch they won’t get filled today, which they really should.
It was a day to step aside.
January Mid-Month Conference Call: 5 Key Takeaways
From the Desk of Steve Strazza @Sstrazza
Last week we held our January Monthly Conference Call, which Premium Members can access and rewatch here.
In this post, we’ll do our best to summarize it by highlighting five of the most important charts and/or themes we covered, along with commentary on each
Let’s get right into it!
The Bullish Trifecta
EcoR1 Reports ZYME, JANX Activity
The largest insider buy on today’s list is a Form 4 filing by EcoR1 Capital LLC, which reported a purchase of roughly $2.9 million in Zymeworks Inc $ZYME.
EcoR1 Capital also filed a Form 13G, disclosing a stake of 7.80% in the cancer biotech stock Janux Therapeutics $JANX.
Swing Trader Pro: Morning Briefing (01-24-2023)
From the Desk of Kimmy Sokoloff
The futures are indicating lower this morning. A healthy digesting is warranted.
I’d like to see 396, roughly, held over the next few days on $SPY.
If we push past 402.70, then we can potentially see 405, the next level above.
Under the Hood (01-23-2023)
From the desk of Steve Strazza @Sstrazza.
Welcome back to Under the Hood, where we’ll cover all the action for the week ended January 20, 2023. This report is published bi-weekly and rotated with The Minor Leaguers.
What we do here is analyze the most popular stocks during the week and find opportunities to either join in and ride these momentum names higher, or fade the crowd and bet against them.
We use a variety of sources to generate the list of most popular names.
There are so many new data sources available that all we need to do is organize and curate them in a way that shows us exactly what we want: a list of stocks that are seeing an unusual increase in investor interest.
Click here for a behind-the-scenes look at our process.
Whether we’re measuring increasing interest based on large institutional purchases, unusual options activity, or simply our proprietary lists of trending tickers, there’s a lot of overlap.
Follow the Flow (01-23-2023)
From the Desk of Steve Strazza @sstrazza and Alfonso Depablos @Alfcharts
This is one of our favorite bottom-up scans: Follow the Flow.
In this note, we simply create a universe of stocks that experienced the most unusual options activity — either bullish or bearish, but not both.
We utilize options experts, both internally and through our partnership with The TradeXchange. Then, we dig through the level 2 details and do all the work upfront for our clients.
Our goal is to isolate only those options market splashes that represent levered and high-conviction, directional bets.
We also weed out hedging activity and ensure there are no offsetting trades that either neutralize or cap the risk on these unusual options trades.
What remains is a list of stocks that large financial institutions are putting big money behind.
And they’re doing so for one reason only: because they think the stock is about to move in their direction and make them a pretty penny.
Then we flip through our list of stocks flashing unusual activity and pick the best setups using many of the same technical filters we do for our other scans.
And, just like that, we’ll follow the money flow and fatten our own pockets along with some of the world’s most powerful financial institutions.
- « Previous Page
- 1
- …
- 191
- 192
- 193
- 194
- 195
- …
- 564
- Next Page »
